MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Enviromental Risk Factors for Parkinson’s Disease in the Nigeria Parkinson’s Disease Research Network

    N. Obianozie, O. Ojo, 0. Agabi, N. Okubadejo, N. Research Network (Abuja, Nigeria)

    Objective: To determine the risk factors associated with Parkinson’s disease (PD) development in the Nigerian PD Research (NPDR) cohort Background: PD is widely believed to…
  • 2024 International Congress

    Effect of Diabetes Mellitus on the Phenotype of Parkinson’s Disease

    IH. Kwak, HI. Ma, YE. Kim, JJ. Lee (Anyang-si, Republic of Korea)

    Objective: In this study, we aim to investigate whether Type 2 diabetes (T2DM) influences the phenotype of Parkinson’s disease (PD). Background: In PD, T2DM may…
  • 2024 International Congress

    EMPOWER-PD: Testing and evaluation of an 8-week co-created Self-management program tailored People with Parkinson`s disease and their caregivers in an interventional follow-up study

    T. Thomsen, S. Skovbølling, M. Brønden, M. Møller, J. Frederiksen, B. Biering-Sørensen (Roskilde, Denmark)

    Objective: This study aims to test a 8-week self-management program, developed collaboratively with People with PD (PwP), caregivers, healthcare professionals and other stakeholders using a…
  • 2024 International Congress

    Increasing access to Deep Brain Stimulation for an underserved patient population: A retrospective cohort from an urban hospital in a diverse county in the USA.

    Y. Xu, J. Acquaviva, A. Castillo, B. Puccio, E. Feinstein (Newark, USA)

    Objective: To understand whether the presence of a Bilingual Movement Disorder specialist increases access to Deep Brain Stimulation (DBS) for an underserved patient population. Background:…
  • 2023 International Congress

    The effect of APOE ε4 on striatal vesicular monoamine transporter-2 density in Parkinson’s disease

    W. Li, R. Li, J. Lu (Beijing, China)

    Objective: To evaluate the effect of apolipoprotein E 4 (APOE 4) on striatal vesicular monoamine transporter-2 (VMAT2) density in Parkinson’s disease (PD).To evaluate the effect…
  • 2023 International Congress

    Evaluation of neuroprotective role of carvacrol via Nrf2-NLRP3 axis in rotenone induced PD mice model

    D. Khatri, S. Shah, K. Tryphena (Hyderabad, India)

    Objective: To explore the antioxidant and anti-inflammatory role of Carvacrol via Nrf2-NLRP3 axis in rotenone induced PD mice model Background: NLRP3 inflammasome mediated neuroinflammation is…
  • 2023 International Congress

    Relationship between balance performance and corticomotor Inhibition in individuals with Parkinson’s disease

    HH. Liu, YR. Yang, YL. Ling, RY. Wang, SJ. Cheng (Taipei City, Taiwan)

    Objective: To explore the possible relationship between corticomotor inhibition assessed by transcranial magnetic stimulation (TMS) and balance performance in individuals with Parkinson’s disease (PD). Also,…
  • 2023 International Congress

    Early cortical atrophy is related to depression in Parkinson’s disease

    E. Backman, L. Saari, R. Parkkola, J. Lötjönen, M. Gardberg, V. Kaasinen (Turku, Finland)

    Objective: To investigate depression in relation to medial temporal lobe atrophy (MTA), global cortical atrophy (GCA) and white matter hyperintensities (WMH) in neuropathologically confirmed patients…
  • 2023 International Congress

    Supine hypertension is longitudinally associated with cognitive decline in Parkinson disease independent of orthostatic hypotension

    C. Miller-Patterson, J. Hsu, M. Barrett, L. Cloud, T. Chelimsky (Richmond, USA)

    Objective: To determine whether orthostatic hypotension (OH) and/or supine hypertension (SH) are longitudinally associated with cognitive decline in Parkinson disease (PD). Background: Cognitive impairment is…
  • 2023 International Congress

    Assessing non-motor symptoms and associations with quality of life among patients in Korle-Bu Teaching Hospital, Ghana

    D. Brodie-Mends, F. Duodu, K. Nkromah, A. Akpalu (Accra, Ghana)

    Objective: To determine the prevalence and types of non-motor symptoms (NMS) and their relation to quality of life among Parkinson’s disease (PD) patients who attend…
  • « Previous Page
  • 1
  • …
  • 190
  • 191
  • 192
  • 193
  • 194
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley